Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 176 Records) |
| Query Trace: Neoplasms and ABCG2[original query] |
|---|
| Effects of CYP3A4/5 and ABC transporter polymorphisms on osimertinib plasma concentrations in Japanese patients with non-small cell lung cancer. Investigational new drugs 2022 9 40 (6): 1254-1262. Yokota Hayato, Sato Kazuhiro, Sakamoto Sho, Okuda Yuji, Fukuda Natsuki, Asano Mariko, Takeda Masahide, Nakayama Katsutoshi, Miura Masato |
| The Association Between Genetic Polymorphisms of Transporter Genes and Prognosis of Platinum-Based Chemotherapy in Lung Cancer Patients. Pharmacogenomics and personalized medicine 2022 15 817-825. He Jia, Wang Zhan, Zou Ting, Wang Ying, Li Xiang-Ping, Chen Ju |
| Dutch pharmacogenetics working group guideline for the gene-drug interaction of ABCG2, HLA-B and Allopurinol, and MTHFR, folic acid and methotrexate. European journal of human genetics : EJHG 2022 9 . van der Pol Karel H, Nijenhuis Marga, Soree Bianca, de Boer-Veger Nienke J, Buunk Anne Marie, Guchelaar Henk-Jan, Risselada Arne, van Schaik Ron H N, Swen Jesse J, Touw Daan, van der Weide Jan, van Westrhenen Roos, Deneer Vera H M, Houwink Elisa J F, Rongen Gerard |
| Genetic variations in ABC transporter genes as a predictive biomarker for toxicity in North Indian lung cancer patients undergoing platinum-based doublet chemotherapy. Journal of biochemical and molecular toxicology 2022 12 e23269. Sharma Parul, Singh Navneet, Sharma Siddhar |
| Pharmacokinetics of gefitinib in elderly patients with EGFR-mutated advanced non-small cell lung cancer: a prospective study. BMC pulmonary medicine 2022 11 22 (1): 454. Nio Yuta, Ishida Hiroo, Matsumoto Natsumi, Kusumoto Sojiro, Kubota Yutaro, Tsunoda Takuya, Sasaki Yasutsuna, Fujita Ken-Ic |
| Loss of Function ABCG2 c.421C>A (rs2231142) Polymorphism Increases Steady-State Exposure to Mycophenolic Acid in Stable Renal Transplant Recipients: An Exploratory Matched Cohort Study. Advances in therapy 2022 11 40 (2): 601-618. Bori?-Biluši? A Ana, Božina Nada, Lali? Zdenka, Lovri? Mila, Na?-Škegro Sandra, Penezi? Luka, Bariši? Karmela, Trkulja Vladim |
| Impacts of pregnane X receptor and cytochrome P450 oxidoreductase gene polymorphisms on trough concentrations of apixaban in patients with non-valvular atrial fibrillation. European journal of clinical pharmacology 2022 11 79 (1): 127-135. Nakagawa Junichi, Kinjo Takahiko, Aiuchi Naoya, Ueno Kayo, Tomita Hirofumi, Niioka Takeno |
| Impact of organic anion transporting polypeptide, P-glycoprotein, and breast cancer resistance protein transporters on observed tamoxifen and endoxifen concentration and adverse effects. Pharmacogenetics and genomics 2022 11 33 (1): 10-18. Keller Denise N, Medwid Samantha J, Ross Cameron D, Wigle Theodore J, Kim Richard |
| Impact of ABCB1, ABCC1, ABCC2, and ABCG2 variants in predicting prognosis and clinical outcomes of north Indian lung cancer patients undergoing platinum-based doublet chemotherapy. The journal of gene medicine 2022 10 25 (1): e3460. Sharma Parul, Singh Navneet, Sharma Siddhar |
| Study of Breast Cancer Resistance Protein ABCG2 C421A Single Nucleotide Polymorphism RS2231142 in Multiple Myeloma. Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion 2022 Oct 38 (4): 658-667. Abbassy Hadeer Aly, Moussa Mayada Aly, Abd Elmoniem Rahma Mohamed, Imbaby Salma Alaa Eld |
| Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancer. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2023 9 167 115479. Elena Peruzzi, Lorenzo Gerratana, Marcella Montico, Bianca Posocco, Serena Corsetti, Michele Bartoletti, Sara Gagno, Marco Orleni, Elena De Mattia, Massimo Baraldo, Erika Cecchin, Fabio Puglisi, Giuseppe Toffoli, Rossana Ronca |
| Irinotecan-Induced Toxicity: A Pharmacogenetic Study Beyond UGT1A1. Clinical pharmacokinetics 2023 9 . Mirjam de With, Leni van Doorn, Esmay Kloet, Anne van Veggel, Maja Matic, Micha J de Neijs, Esther Oomen-de Hoop, Esther van Meerten, Ron H N van Schaik, Ron H J Mathijssen, Sander Bi |
| ABCG2 Gene Polymorphisms May Affect the Bleeding Risk in Patients on Apixaban and Rivaroxaban. Drug design, development and therapy 2023 8 17 2513-2522. Hamin Kim, Tae-Jin Song, Jeong Yee, Dong-Hyeok Kim, Junbeom Park, Hye Sun Gw |
| Influence of germline variations in drug transporters ABCB1 and ABCG2 on intracerebral osimertinib efficacy in patients with non-small cell lung cancer. EClinicalMedicine 2023 5 59 101955. G D Marijn Veerman, Rene J Boosman, Merel Jebbink, Esther Oomen-de Hoop, Anthonie J van der Wekken, Idris Bahce, Lizza E L Hendriks, Sander Croes, Christi M J Steendam, Evert de Jonge, Stijn L W Koolen, Neeltje Steeghs, Ron H N van Schaik, Egbert F Smit, Anne-Marie C Dingemans, Alwin D R Huitema, Ron H J Mathijss |
| Pilot Study on the Impact of Polymorphisms Linked to Multi-Kinase Inhibitor Metabolism on Lenvatinib Side Effects in Patients with Advanced Thyroid Cancer. International journal of molecular sciences 2023 3 24 (6): . Cantara Silvia, Dalmiglio Cristina, Marzocchi Carlotta, Sagnella Alfonso, Brilli Lucia, Trimarchi Andrea, Maino Fabio, Valerio Laura, Castagna Maria Graz |
| Effects of ABCB1 and ABCG2 Polymorphisms on the Pharmacokinetics of Abemaciclib Metabolites (M2, M20, M18). Anticancer research 2023 2 43 (3): 1283-1289. Maeda Akimitsu, Ando Hitoshi, Irie Kei, Hashimoto Naoya, Morishige Jun-Ichi, Fukushima Shoji, Ebi Hiromichi, Uchida Kosaku, Iwata Hiroji, Sawaki Masata |
| Risk Factors for Rivaroxaban-Related Bleeding Events-Possible Role of Pharmacogenetics: Case Series. Pharmacy (Basel, Switzerland) 2023 2 11 (1): . Šimi?evi? Livija, Sliškovi? Ana Marija, Kirhmajer Majda Vrki?, Ganoci Lana, Holik Hrvoje, Pali? Jozefina, Samardži? Jure, Božina Tama |
| Effect of genetic polymorphisms on the pharmacokinetics of gefitinib in healthy Chinese volunteers. Xenobiotica; the fate of foreign compounds in biological systems 2023 12 1-28. Ying-Rong Chen, Xiang Yu, Li-Min Xu, Jue Mei, Meng-Li Tian, Min Xu, Qiu-Yue Jin, Li-Bing Ye, Shui-Xin Ya |
| CYP450 and drug efflux transporters polymorphism influence clinical outcomes of Thai osimertinib-treated non-small cell lung cancer patients. Frontiers in pharmacology 2023 11 14 1222435. Teerapat Majam, Chonlaphat Sukasem, Thanyanan Reungwetwattana, Phichai Chansriwong, Chalirmporn Atasilp, Narumol Trachu, Thanaporn Thamrongjirapat, Rattanaporn Sukprasong, Jennis Meanwattha |
| Breast cancer resistance protein polymorphism ABCG2 c.421C>A (rs2231142) moderates the effect of valproate on lamotrigine trough concentrations in adults with epilepsy. Fundamental & clinical pharmacology 2023 10 . Ivana Šušak Sporiš, Nada Božina, Iva Klarica Domjanovi?, Davor Sporiš, Silvio Baši?, Ivana Baši?, Mila Lovri?, Lana Ganoci, Vladimir Trkul |
| Population Pharmacokinetics, Pharmacogenomics, and Adverse Events of Osimertinib and its Two Active Metabolites, AZ5104 and AZ7550, in Japanese Patients with Advanced Non-small Cell Lung Cancer: a Prospective Observational Study. Investigational new drugs 2023 1 . Ishikawa Emi, Yokoyama Yuta, Chishima Haruna, Kasai Hidefumi, Kuniyoshi Ouki, Kimura Motonori, Hakamata Jun, Nakada Hideo, Suehiro Naoya, Nakaya Naoki, Nakajima Hideo, Ikemura Shinnosuke, Kawada Ichiro, Yasuda Hiroyuki, Terai Hideki, Jibiki Aya, Kawazoe Hitoshi, Soejima Kenzo, Muramatsu Hiroshi, Suzuki Sayo, Nakamura Tomono |
| Effect of Genetic Polymorphisms of ABCB1, ABCG2, and SLC22A1 on the Steady-State Plasma Concentrations of Lamotrigine in Treatment-Resistant Depressed Patients Treated With Lamotrigine Augmentation Therapy. Clinical neuropharmacology 2024 8 . Yoko Tomori, Takeshi Suzuki, Kazuo Mihara, Goyo Nagai, Shoko Kagawa, Akifumi Nakamura, Kenji Nemoto, Tsuyoshi Kon |
| Comprehensive breast cancer risk analysis with whole exome sequencing and the prevalence of BRCA1 and ABCG2 mutations and oncogenic HPV. Biomedical reports 2024 8 21 (4): 144. Sureewan Bumrungthai, Sureewan Duangjit, Supaporn Passorn, Sutida Pongpakdeesakul, Siriwoot Butsri, Somwang Janyakhantik |
| Potential association of SULT2A1 and ABCG2 variant alleles with increased risk for palbociclib toxicity. Pharmacogenomics 2024 8 1-9. Chong Wang, Mary Hwang, Brandon Paulson, Doreen Mhandire, Sadat Ozair, Tracey L O'Connor, Shipra Gandhi, Kristopher M Attwood, Daniel L Hertz, Andrew Kl Go |
| Transporter Genes and statin-induced Hepatotoxicity. Cardiovascular drugs and therapy 2024 5 . Seo-A Choi, Jung Sun Kim, Yoon-A Park, Da Hoon Lee, Minju Park, Jeong Yee, Yoonkyung Chang, Tae-Jin Song, Hye Sun Gw |
| Factors Influencing Mortality in Children with Central Nervous System Tumors: A Cohort Study on Clinical Characteristics and Genetic Markers. Genes 2024 4 15 (4): . Luz María Torres-Espíndola, Juan Carlos Pérez-De Marcos, Manuel Castillejos-López, Liliana Velasco-Hidalgo, Rocío Cárdenas-Cardós, Armando De Uña-Flores, Citlaltepetl Salinas-Lara, Silvia Caballero-Salazar, Rosario Fernández-Plata, Arnoldo Aquíno-Gálv |
| Impact of ABCG2 rs2231142(421C>A) Variant on the Clinical Outcomes of Patients With EGFR-mutated Non-small Cell Lung Cancer Treated With Gefitinib: A Comprehensive Meta-analysis. Anticancer research 2024 12 44 (12): 5361-5370. Francisco Cezar Aquino DE Moraes, Maria Eduarda Cavalcanti Souza, Emanuele Rocha DA Silva, Michele Kreuz, Rommel Mario Rodriguez Burba |
| Association Between ABCC2 -24C>T and Nab-Paclitaxel-induced Peripheral Neuropathy in Japanese Patients With Pancreatic Cancer. Anticancer research 2024 10 44 (11): 5023-5033. Hana Nakayama, Hiroo Ishida, Masanori Iidaka, Shoko Kato, Kei Nakatani, Akihiro Nakayama, Toshihiro Noguchi, Shigetoshi Nishihara, Shu Oikawa, Tomono Usami, Yuta Mitsui, Y U Ishii, Hirokazu Toshima, Kouji Kobayashi, Remi Murase, Natsumi Matsumoto, Kosuke Suzuki, Ken Shimada, Hitoshi Yoshida, Ken-Ichi Fuji |
| Vitamin D receptor induces oxidative stress to promote esophageal squamous cell carcinoma proliferation via the p53 signaling pathway. Heliyon 2024 1 10 (1): e23832. Qi-Xin Shang, Yu-Shang Yang, Han-Lu Zhang, Ya-Ping Cheng, Han Lu, Yong Yuan, Long-Qi Chen, Ai-Fang |
| Variants of the ABCG2 gene in Mexican mestizo patients with prostate cancer. Cellular and molecular biology (Noisy-le-Grand, France) 2025 1 70 (12): 180-187. Gabriela Monserrat Mimendi-Aguilar, Michael Dean, Silvia Esperanza Flore-Martínez, Alejandra Guadalupe García-Zapien, José Sánchez-Corona, María Fernanda Romero-Morán, Martha Arisbeth Villanueva-Pérez, Erick Sierra-Díaz, Salvador Sánchez-Benavides, Ingrid Patricia Dávalos-Rodríguez, Jesús Alejandro Juárez-Ozuna, Mónica Alejandra Rosales-Reynoso, Maria Cristina Morán Mogu |
- Page last reviewed:Feb 1, 2024
- Content source: